On ECHEMI
Home > Drugs > Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
  • Founded in:

    1993-12-31
  • Country:

    China China
  • Address:

    No. 23, No. 8 Street, Baiyang Street, Qiantang District, Hangzhou City, Zhejiang Province
  • Tax NO.:

    91330100609130315G
  • Registered Funds:

    245.3988 million yuan
  • Website:

  • Email:

Related Drugs
Recombinant human granulocyte-stimulating factor injection
recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Recombinant human granulocyte-stimulating factor injection
recombinant human granulocyte colony stimulating factor
Name Description Content CAS NO. Registered Holders
HumanGranulocyteColonyStimulatingFactor

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

More

This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.

0
Enoxaparin Sodium Injection
Active ingredient: Enoxaparin.
Name Description Content CAS NO. Registered Holders
HEPARIN

9005-49-6 16
Enoxaparin Sodium Injection
Active ingredient: Enoxaparin.
Name Description Content CAS NO. Registered Holders
HEPARIN

9005-49-6 16
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.